Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan

British Journal of Haematology

Volumn 147, Issue 4, 2009, Pages 554-560

  Cappelli, Barbara ^a,b   Chiesa, Robert ^a,b   Evangelio, Costanza ^a   Biffi, Alessandra ^a,b   Roccia, Tito ^a   Frugnoli, Ilaria ^a   Biral, Erika ^a,b   Noè, Anna ^a   Fossati, Marco ^a   Finizio, Valentina ^a   Miniero, Roberto ^a   Napolitano, Sara ^a   Ferrua, Francesca ^a   Soliman, Clara ^a,b   Ciceri, Fabio ^a   Roncarolo, Maria G ^a,b,c   Marktel, Sarah ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Busulphan; Defibrotide; Paediatric; Thalassemia; Veno occlusive disease

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BUSULFAN; CYCLOSPORIN A; CYTARABINE; DEFIBROTIDE; DOPAMINE; FLUDARABINE; FUROSEMIDE; HYDROXYUREA; MEPREDNISONE; METHOTREXATE; PENTAMIDINE; SPIRONOLACTONE; THIOTEPA; THYMOCYTE ANTIBODY; VITAMIN K GROUP;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BETA THALASSEMIA; BLEEDING; CHILD; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG FORMULATION; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON OVERLOAD; LIVER FIBROSIS; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; OPTIMAL DRUG DOSE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTE TRANSFUSION;

ADOLESCENT; BETA-THALASSEMIA; BUSULFAN; CHILD; CHILD, PRESCHOOL; DRUG EVALUATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PLATELET AGGREGATION INHIBITORS; POLYDEOXYRIBONUCLEOTIDES; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING;

EID: 70350433279     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07871.x     Document Type: Article

References (38)

1. Angelucci, E., Muretto, P., Nicolucci, A., Baronciani, D., Erer, B., Gaziev, J., Ripalti, M., Sodani, P., Tomassoni, S., Visani, G. Lucarelli, G. (2002) Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood, 100, 17 21.
2. Baron, F., Deprez, M. Beguin, Y. (1997) The veno-occlusive disease of the liver. Haematologica, 82, 18 25.
3. Bulley, S.R., Strahm, B., Doyle, J. Dupuis, L.L. (2007) Defibrotide for the treatment of hepatic veno-occlusive disease in children. Pediatric Blood Cancer, 48, 700 704.
4. Carreras, E. (2000) Veno-occlusive disease of the liver after hemopoietic cell transplantation. European Journal of Haematology, 64, 281 291.
5. Carreras, E., Bertz, H., Arcese, W., Vernant, J.P., Tomás, J.F., Hagglund, H., Bandini, G., Esperou, H., Russell, J., de la Rubia, J., Di Girolamo, G., Demuynck, H., Hartmann, O., Clausen, J., Ruutu, T., Leblond, V., Iriondo, A., Bosi, A., Ben-Bassat, I., Koza, V., Gratwohl, A. Apperley, J.F. (1998) Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood, 92, 3599 3604.
6. Cesaro, S., Pillon, M., Talenti, E., Toffolutti, T., Calore, E., Tridello, G., Strugo, L., Destro, R., Gazzola, M.V., Varotto, S., Errigo, G., Carli, M., Zanesco, L. Messina, C. (2005) A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica, 90, 1396 1404.
7. Chalandon, Y., Roosnek, E., Mermillod, B., Newton, A., Ozsahin, H., Wacker, P., Helg, C. Chapuis, B. (2004) Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 10, 347 354.
8. Cheuk, D.K., Wang, P., Lee, T.L., Chiang, A.K., Ha, S.Y., Lau, Y.L. Chan, G.C. (2007) Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplantation, 40, 935 944.
9. Chopra, R., Eaton, J.D., Grassi, A., Potter, M., Shaw, B., Salat, C., Neumeister, P., Finazzi, G., Iacobelli, M., Bowyer, K., Prentice, H.G. Barbui, T. (2000) Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. British Journal of Haematology, 111, 1122 1129.
10. Corbacioglu, S., Greil, J., Peters, C., Wulffraat, N., Laws, H.J., Dilloo, D., Straham, B., Gross-Wieltsch, U., Sykora, K.W., Ridolfi-Lüthy, A., Basu, O., Gruhn, B., Güngör, T., Mihatsch, W. Schulz, A.S. (2004) Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplantation, 33, 189 195.
11. Corbacioglu, S., Hönig, M., Lahr, G., Stöhr, S., Berry, G., Friedrich, W. Schulz, A.S. (2006) Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplantation, 38, 547 553.
12. Dignan, F., Gujral, D., Ethell, M., Evans, S., Treleaven, J., Morgan, G. Potter, M. (2007) Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease. Bone Marrow Transplantation, 40, 79 82.
13. Essell, J.H., Thompson, J.M., Harman, G.S., Halvorson, R.D., Snyder, M.J., Johnson, R.A. Rubinsak, J.R. (1992) Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide. Blood, 79, 2784 2788.
14. Istituto Poligrafo dello Stato, Rome, Italy (2008) Farmacopea Ufficiale, XII Edition, 1417 1426.
15. Frickhofen, N., Wiesneth, M., Jainta, C., Hertenstein, B., Heymer, B., Bianchi, L., Dienes, H.P., Koerner, K., Bunjes, D. Arnold, R. (1994) Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood, 83, 1998 2004.
16. Gaziev, J., Sodani, P., Lucarelli, G., Polchi, P., Marktel, S., Paciaroni, K., Marziali, M., Isgrò, A., Simone, M.D., Roveda, A., Montuoro, A., Lanti, A., Alfieri, C., De Angelis, G., Gallucci, C., Ciceri, F. Roncarolo, M.G. (2008) Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft. Bone Marrow Transplantation, 42, 397 404.
17. Ho, V.T., Linden, E., Revta, C. Richardson, P.G. (2007) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide. Seminars in Thrombosis and Hemostasis, 33, 373 388. Review.
18. Ho, V.T., Revta, C. Richardson, P.G. (2008) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transplantation, 41, 229 237.
19. Hod, E. Schwartz, J. (2008) Platelet transfusion refractoriness. British Journal of Haematology, 142, 348 360.
20. Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R.N., Phillips, M.J., Portmann, B., Paulsen, H., Scheuer, P.J., Schmid, M. Thaler, H. (1995) Histological grading and staging of chronic hepatitis. Journal of Hepatology, 22, 696 699.
21. Jastaniah, W., Harmatz, P., Pakbaz, Z., Fischer, R., Vichinsky, E. Walters, M.C. (2008) Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatric Blood Cancer, 50, 319 324.
22. Lazarus, H.M. McCrae, K.R. (2008) SOS Defibrotide to the rescue. Blood, 112, 3924 3925.
23. Lee, J.H., Choi, S.J., Lee, J.H., Kim, S.E., Park, C.J., Chi, H.S., Lee, M.S., Lee, J.S., Kim, W.K. Lee, K.H. (2005) Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation. Annals in Hematology, 84, 321 330.
24. Li, C.K., Yuen, P.M., Wong, R., Pang, C.P., Lai, W.K., Law, E., Shing, M.M., Chik, K.W. Leung, T.F. (1999) Busulphan level and early mortality in thalassaemia patients after BMT. Bone Marrow Transplantation, 23, 307 310.
25. Lucarelli, G. Gaziev, J. (2008) Advances in the allogeneic transplantation for thalassemia. Blood Reviews, 22, 53 63.
26. Lucarelli, G., Galimberti, M., Polchi, P., Angelucci, E., Baronciani, D., Giardini, C., Politi, P., Durazzi, S.M., Muretto, P. Albertini, F. (1990) Bone marrow transplantation in patients with thalassemia. New England Journal of Medicine, 322, 417 421.
27. Majhail, N.S., Mothukuri, J.M., Brunstein, C.G. Weisdorf, D.J. (2009) Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Biology of Blood and Marrow Transplantation, 15, 564 573.
28. McDonald, G.B., Hinds, M.S., Fisher, L.D., Schoch, H.G., Wolford, J.L., Banaji, M., Hardin, B.J., Shulman, H.M. Clift, R.A. (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Annals of Internal Medicine, 118, 255 267.
29. Morado, M., Ojeda, E., Garcia-Bustos, J., Aguado, M.J., Arrieta, R., Quevedo, E., Navas, A. Hernandez-Navarro, F. (2000) BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective Cohort Study. Hematology, 4, 505 512.
30. Pullarkat, V., Blanchard, S., Tegttmeier, B., Dagis, A., Patane, K., Ito, J. Forman, S.J. (2008) Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 42, 799 805.
31. Qureshi, A., Marshall, L. Lancaster, D. (2008) Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children. Pediatric Blood Cancer, 50, 831 832.
32. Reiss, U., Cowan, M., McMillan, A. Horn, B. (2002) Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. Journal of Pediatric Hematology/Oncology, 24, 746 750.
33. Richardson, P.G., Murakami, C., Jin, Z., Warren, D., Momtaz, P., Hoppensteadt, D., Elias, A.D., Antin, J.H., Soiffer, R., Spitzer, T., Avigan, D., Bearman, S.I., Martin, P.L., Kurtzberg, J., Vredenburgh, J., Chen, A.R., Arai, S., Vogelsang, G., McDonald, G.B. Guinan, E.C. (2002) Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood, 15, 4337 4343.
34. Schechter, T., Finkelstein, Y., Doyle, J., Verjee, Z., Moretti, M., Koren, G. Dupuis, L.L. (2007) Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation. Biology Blood and Marrow Transplantation, 13, 307 314.
35. Sodani, P., Gaziev, D., Polchi, P., Erer, B., Giardini, C., Angelucci, E., Baronciani, D., Andreani, M., Manna, M., Nesci, S., Lucarelli, B., Clift, R.A. Lucarelli, G. (2004) New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood, 104, 1201 1203.
36. Sucak, G.T., Aki, Z.S., Yagcí, M., Yegin, Z.A., Ozkurt, Z.N. Haznedar, R. (2007) Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience. Transplantation Proceedings, 39, 1558 1563.
37. Vassal, G., Michel, G., Espérou, H., Gentet, J.C., Valteau-Couanet, D., Doz, F., Mechinaud, F., Galambrun, C., Neven, B., Zouabi, H., Nguyen, L. Puozzo, C. (2008) Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring. Cancer Chemotherapy and Pharmacology, 61, 113 123.
38. Versluys, B., Bhattacharaya, R., Steward, C., Cornish, J., Oakhill, A. Goulden, N. (2004) Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure. Blood, 103, 1968.